Mira Kassouf: Reactivating An Embryonic Gene To Treat α-Thalassemia
Mira Kassouf, Principal Investigator at University of Oxford, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Nature Genetics, adding:
”Very excited to see our work now published in Nature Genetics!
‘Reactivation of the embryonic ζ-globin gene ameliorates severe forms of α-thalassemia’
This work started with a fundamental question: how is an embryonic gene switched off during development, and could we switch it back on?
Using the α-globin locus as our model, we identified key regulatory DNA elements that silence the embryonic ζ-globin (HBZ) gene. By precisely editing these elements, we were able to reactivate ζ-globin in mouse models and, importantly, in primary erythroid cells from patients with severe α-thalassaemia.
The work provides proof-of-principle for an exciting therapeutic concept: rather than replacing a missing or defective adult gene, could we unlock a functional gene that our genome already contains but has switched off during development?
This has been a fantastic team effort, led by Siyu Liu, and made possible by the contributions of many colleagues and collaborators. I am particularly grateful to the patients and families who contributed samples to this research.
The next phase of this work will focus on advancing the approach towards a regulatory-ready stage, addressing the efficacy, safety and delivery requirements needed to support future clinical translation and, ultimately, its development as a therapy for severe α-thalassaemia.
A huge congratulations and thank you to everyone involved!”
Title: Reactivation of the embryonic ζ-globin gene ameliorates severe forms of α-thalassemia
Authors: Siyu Liu, Ayesha Ejaz, Andrew J. King, Aude-Anais Olijnik, Jacqueline Sloane-Stanley, Caroline Scott, Ali Amid, Daniel Biggs, Benjamin Davies, Jennifer Eglinton, Gabriella Martyn, Merlin Crossley, Christian Babbs, Mira T. Kassouf, Douglas R. Higgs

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 00:33Overcoming Barriers to Diagnosis and Treatment for Women With Bleeding Disorders – EHC
-
Nov 20, 2026, 00:27Vera Stroikova: Key Takeaways on Electrophysiology and Stroke Prevention From the New Horizons 2026
-
Nov 20, 2026, 00:20Devi G. Nair Enrolls First US Patient in Smartphone Camera Atrial Fibrillation Detection Study
-
Nov 20, 2026, 00:14Saskia de Pee: Fortified Rice Cuts Anemia Risk by 57%
-
Nov 20, 2026, 00:02Andres Zuleta: Evaluating the RISE UP Trial Results on Mitapivat for Sickle Cell Disease
-
Nov 19, 2026, 23:57Greta Hametner: Preventing Maternal Cardiac Complications Through Preconception Iron and Thyroid Screening
-
Nov 19, 2026, 23:49Cyrus Shariat: Why Waiting for Lab Results Can Be Fatal in HIT
-
Nov 19, 2026, 22:24Erik Nelson: Low Iron Can Raise A1c without Changing Blood Sugar
-
Nov 19, 2026, 22:23Erwin Loh: Daily Iron Supplementation Reduces Iron-Deficiency Anaemia in Children and Adolescents